Lung Cancer Considered

Lung Cancer Considered

Dr. Stephen Liu and Dr. Narjust Florez host Lung Cancer Considered, the podcast of The International Association for the Study of Lung Cancer (IASLC). IASLC is the only global organization dedicated solely to the study of lung cancer and other thoracic malignancies. Founded in 1974, the association's membership includes more than 11,000 lung cancer specialists across all disciplines in over 100 countries, forming a global network working together to conquer lung and thoracic cancers worldwide. The association also publishes the Journal of Thoracic Oncology, the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis and treatment of all thoracic malignancies. Visit www.iaslc.org for more information. Lung Cancer considered is funded in part by Current sponsors: • AbbVie • AstraZeneca • Gilead • J&J • Summit

Den här podcasten är hämtad från ett öppet RSS-flöde och publiceras inte av Podme. Den kan innehålla reklam.

Avsnitt(401)

Clinical Discussion in the Management of Early-Stage NSCLC

Clinical Discussion in the Management of Early-Stage NSCLC

In this episode of Lung Cancer Considered, host Dr. Narjust Florez moderates a discussion on the management of early-stage disease, with an eye toward applying conclusions from trials such as the ADAU...

23 Juli 202454min

LCC: The Management Of CNS Metastases In Driver Negative NSCLC

LCC: The Management Of CNS Metastases In Driver Negative NSCLC

Description: Host Dr. Narjust Florez and two esteemed international clinicians discuss the unique characteristics of CNS metastases in patients with non-small cell lung cancer and small cell lung can...

16 Juli 202447min

Lung Cancer Considered in Romanian

Lung Cancer Considered in Romanian

Continuing our series of podcasts in different world languages, this episode focuses on lung cancer research and treatment in Romanian. Host: Mihaela Aldea, MD PhD Thoracic Oncology and Precision M...

8 Juli 202435min

The Importance of Waiting for Biomarker Results in NSCLC

The Importance of Waiting for Biomarker Results in NSCLC

Biomarkers are essential in lung cancer treatment, but they remain underutilized. In addition, clinicians and patients have to wait for those results before starting therapy. In this episode of Lung C...

2 Juli 202450min

LCC In Italian--First-Line Treatment Options for EGFR Mutant NSCLC

LCC In Italian--First-Line Treatment Options for EGFR Mutant NSCLC

This episode of Lung Cancer Considered discusses first-line treatment options for EGFR mutant NSCLC, in Italian. Guest: Dr. Jessica Menis is a thoracic medical oncologist with expertise in early-pha...

20 Juni 202447min

FDA Approval Of Tarlartamab

FDA Approval Of Tarlartamab

In this episode of Lung Cancer Considered, host Dr. Stephen Liu discusses the recently approved bispecific T-cell engager, tarlatamab, for small cell lung cancer. Guest: Dr. Anne-Marie Dingemans is a...

18 Juni 202431min

ASCO 2024 Summary Part 2

ASCO 2024 Summary Part 2

In episode two summarizing important lung cancer data presented at ASCO 2024, Lung Cancer Considered hosts Dr. Narjust Florez and Dr. Stephen Liu cover the phase III CROWN trial, ROS1 NSCLC with a nov...

14 Juni 202449min

IASLC - ASCO 2024 Summary--Part 1

IASLC - ASCO 2024 Summary--Part 1

Title: ASCO 2024 Highlights Part 1 - Plenary Description: ASCO 2024 had so much lung cancer data, two podcast episodes are required to cover all the data presented. In this first episode, hosts Dr. S...

11 Juni 202448min

Populärt inom Vetenskap

p3-dystopia
dumma-manniskor
allt-du-velat-veta
kapitalet-en-podd-om-ekonomi
ufo-sverige
medicinvetarna
halsorevolutionen
rss-vetenskapsradion
rss-ufobortom-rimligt-tvivel
sexet
rss-spraket
det-morka-psyket
ufo-sverige-2
paranormalt-med-caroline-giertz
dumforklarat
ideer-som-forandrar-varlden
vetenskapsradion
rss-vetenskapsradion-2
svd-nyhetsartiklar
bildningspodden